3rd Annual Gene Therapy Patient Engagement Summit

The role of patient engagement in gene therapy development is changing.
As the global healthcare system accelerates its acceptance of gene therapies as one-time, potentially curative, treatment options for rare diseases, the role of patient engagement in informing drug development strategy is evolving.

Time: 9:00 am – 4:00 pm

Venue details: The Westin Boston Seaport, 425 Summer Street, Boston, Massachusetts, 02210, United States

Prices:
Conference + Workshop Day – Industry Rate: USD 4446.00,
Conference Only – Industry Rate: USD 2799.00,
Conference + Workshop Day – Standard Rate: USD 5446.00,
Conference Only – Standard Rate: USD 3499.00

Speakers: Alison Kujawski, Senior Outreach Manager, American Society of Cell and Gene Therapy, Amanda Rohrig, Director – Patient Advocacy, Bridge Bioscience Corp, Andrea Wilkinson, Global Head, Patient Engagement Portfolio Strategy UCB, Behtash Bahador, Director, Health Literacy, CISCRP, and more.